Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperpolarized 13C-Pyruvate MR Spectroscopy in Brain Metastases
NCT03324360Phase 1Recruiting
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Dec 2017
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of hyperpolarized 13C-pyruvate in brain metastases (3 arms), sponsored by Sunnybrook Health Sciences Centre. Primary endpoint: Is an MRI image produced? Y/N? Started Dec 2017; status: recruiting.
02
Drugs
hyperpolarized 13C-pyruvate
03
Conditions
brain metastases
Beyond the preview
Go deeper on NCT03324360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03324360.